Dietary Supplement Recalled for Iodine Content Exceeding Label Claims
Veridance Pharmacal is recalling 450 bottles of Omni-Macs McDonagh Medical Center Dietary Supplement because iodine levels exceed what is claimed on the label. One customer in Gladstone, Missouri received the affected product.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: This is an FDA Class II recall with no reported illnesses or injuries. The hazard is a labeling error in which iodine content exceeds the label claim. Limited distribution and absence of reported health incidents place this in the 'minor labeling errors' category.
Plain-English summary
Veridance Pharmacal, LLC is recalling 450 bottles of Omni-Macs McDonagh Medical Center Dietary Supplement (100 capsules per bottle) due to iodine levels exceeding the amount stated on the product label.
The supplement is intended to be taken at 1-3 capsules per day with meals. The affected bottles were distributed to one customer located in Gladstone, Missouri. Lot codes include 0311-01 (expiration 3/26), 0311-02 (expiration 3/26), and 0367-01 (expiration 8/26).
Consumers who have purchased this product should not take it and should return it to the point of purchase. Anyone who has consumed this supplement and has concerns about their health should contact their healthcare provider.
The recalled product
- Product
- Omni-Macs McDonagh Medical Center Dietary Supplement 100 CAPSULES, Suggested Use: 1-3 capsules per day with meals, Distributed by: McDonagh Medical Center Gladstone, MO 64119
- Manufacturer
- Veridance Pharmacal, LLC
- Category
- Drug — Dietary Supplement
- Hazard
- iodine-excess
- labeling-error
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (4)
- UPC: 850038221294
- Lot codes: 0311-01 exp. 3/26
- 0311-02 exp. 3/26
- 0367-01 exp. 8/26
Distribution
Distributed in 1 state:
- MO
Related recalls
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- ModerateFDA Recalls Pred Mild Ophthalmic Suspension Due to Failed Stability Specifications
FDA (Drugs) · 2026-06-03
- ModerateNicotine Transdermal System Patches Recalled for Oxidative Impurity Specification Failure
FDA (Drugs) · 2026-06-03
- LowPrimidone Tablets Recalled Due to Cross-Contamination with Acemetacin
FDA (Drugs) · 2026-05-27
- HighLiraglutide Injection Recalled Due to Particulate Matter in Cartridges
FDA (Drugs) · 2026-05-27